# A Study to Evaluate the Effect of 2 Drugs on the Pharmacokinetics of BMS-986205 in Healthy Subjects

> **NCT03346837** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 53 (actual)

## Conditions studied

- Malignancies Multiple

## Interventions

- **DRUG:** BMS-986205
- **DRUG:** Itraconazole
- **DRUG:** Rifampin

## Key facts

- **NCT ID:** NCT03346837
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-22
- **Primary completion:** 2017-12-20
- **Final completion:** 2017-12-20
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2018-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03346837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03346837, "A Study to Evaluate the Effect of 2 Drugs on the Pharmacokinetics of BMS-986205 in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03346837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*